Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,294 papers from all fields of science
Search
Sign In
Create Free Account
Recurrent Gastrointestinal Stromal Tumor
The reemergence of a gastrointestinal stromal tumor after a period of remission.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
14 relations
C-KIT Gene
Connective Tissue Cells
Connective and Soft Tissue
Interstitial Cells of Cajal
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Mesenteric fibromatosis after resection for gastrointestinal stromal tumor of stomach
Yi-Tsui Chu
,
Qingqu Guo
,
Dan Wu
Medicine
2017
Corpus ID: 26697145
Rationale: Gastrointestinal stromal tumor and mesenteric fibromatosis are rare mesenchymal tumors. Coexistence of these two…
Expand
2014
2014
[Clinical experience of imatinib mesylate for metastatic or recurrent gastrointestinal stromal tumor].
T. Toyokawa
,
Y. Yamashita
,
+6 authors
Y. Nishiguchi
Gan to kagaku ryoho. Cancer & chemotherapy
2014
Corpus ID: 25641922
We examined the clinical results of 15 patients treated with imatinib mesylate for metastatic or recurrent gastrointestinal…
Expand
Review
2014
Review
2014
[Long-term survival in a case of recurrent gastrointestinal stromal tumor treated with intermittent or low-dose imatinib].
Yoshihiro Kurata
,
S. Takaishi
,
+6 authors
H. Matsubara
Gan to kagaku ryoho. Cancer & chemotherapy
2014
Corpus ID: 35658319
A 65-year-old woman with a gastrointestinal stromal tumor(GIST)underwent a total gastrectomy in 1999. In 2004, she was diagnosed…
Expand
2009
2009
[A case of recurrent gastrointestinal stromal tumor of the stomach with complete response to imatinib mesilate].
T. Aoyama
,
H. Saeki
,
+7 authors
M. Masuda
Gan to kagaku ryoho. Cancer & chemotherapy
2009
Corpus ID: 11389340
We report a patient who long had a complete response by chemotherapy with imatinib mesilate(IM)for locally recurrent…
Expand
2009
2009
Long-term follow-up of imatinib mesylate treatment for patients with recurrent gastrointestinal stromal tumor : liver metastases was not a predictor for poor outcome
Jiang Zhu
,
Yu Yang
,
Lin Zhou
,
M. Jiang
,
M. Hou
2009
Corpus ID: 38260380
Background About 80% patients with GIST would experience tumor recurrence or metastases after a prior radical resection. The most…
Expand
2008
2008
Gastric carcinoid tumor in a patient with a past history of gastrointestinal stromal tumor of the stomach.
Chien-Yuan Hung
,
Ming‐Jen Chen
,
+4 authors
Wen‐Hsiung Chang
World Journal of Gastroenterology
2008
Corpus ID: 38586950
Gastrointestinal stromal tumor is the most common mesenchymal tumor in the gastrointestinal tract. It may coexist with other type…
Expand
2008
2008
Surgery in patients with metastatic or recurrent gastrointestinal stromal tumor (GIST) upon best response or limited progression following imatinib therapy
U. Ronellenfitsch
,
C. Mussi
,
+7 authors
A. Gronchi
2008
Corpus ID: 74153816
10555 Background: Indication and best timing of surgery for metastatic and recurrent GIST treated with imatinib are not clearly…
Expand
2008
2008
[Risk factors and surgical treatment of recurrent gastrointestinal stromal tumor in the rectum].
Y. Zhong
,
Zhixiang Zhou
,
+4 authors
P. Zhao
Zhonghua wei chang wai ke za zhi = Chinese…
2008
Corpus ID: 12399530
OBJECTIVE To investigate the risk factors and surgical treatment of recurrent gastrointestinal stromal tumors in the rectum…
Expand
2006
2006
Recurrent gastrointestinal stromal tumor (GIST).
F. van der Straaten
The Belgian Journal of Radiology
2006
Corpus ID: 77042033
Background: A 39-year-old man presented in 1986 with a tumor of the descending part of the duodenum.The histological diagnosis…
Expand
2004
2004
High efficacy of imatinib for recurrent gastrointestinal stromal tumor in the jejunum: a case report.
K. Yokoi
,
N. Tanaka
,
+7 authors
T. Tajiri
Journal of Nippon Medical School = Nippon Ika…
2004
Corpus ID: 2940432
Gastrointestinal stromal tumor is a mesenchymal tumor of the digestive tract. Although there used to be no effective therapy for…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE